领先多组学科技
精准评估当前的健康状况和疾病风险
云检医学慢性病早期风险评估产品基于质谱法(LC-MS)检测血液中2000余种代谢物分析,结合人工智能机器学习构建2型糖尿病、早期肾损伤、高尿酸血症模型。定期监测血清中多组学物质的变化,能全面且动态地进行2型糖尿病、早期肾损伤、高尿酸血症的早期风险评估,精准识别当前健康状况,独立预警疾病风险。
1. Zhu L, Huang Q, Li X, et al. Serological Phenotyping Analysis Uncovers a Unique Metabolomic Pattern Associated With Early Onset of Type 2 Diabetes Mellitus. Front Mol Biosci. 2022 Apr 8;9:841209.
2. Pereira PR, Carrageta DF, Oliveira PF, et al. Metabolomics as a tool for the early diagnosis and prognosis of diabetic kidney disease. Med Res Rev. 2022 Jul;42(4):1518-1544.
3. Qin N, Qin M, Shi W, et al. Investigation of pathogenesis of hyperuricemia based on untargeted and targeted metabolomics. Sci Rep. 2022 Aug 17;12(1):13980.
服务热线
400-106-1196
云检医学